SCHEMBL6348806

SCHEMBL6348806

CC(c1ccc(O)cc1)c1ccc(N(C)C)cc1.[NaH]

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.67
ESR2 Q92731 2/20 0.67
PDCD1 Q15116 1/20 0.67
CD274 Q9NZQ7 1/20 0.67
APP P05067 2/20 0.53
ALDH1A1 P00352 5/20 0.46
TSHR P16473 3/20 0.46
ALOX15 P16050 2/20 0.46
HSD17B10 Q99714 1/20 0.46
GAA P10253 3/20 0.42
ATM Q13315 1/20 0.42
MAPT P10636 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
MAPK1 P28482 1/20 0.42
PHLPP2 Q6ZVD8 1/20 0.42
SLC2A1 P11166 2/20 0.41
CRHBP P24387 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6339189 0.98 ESR1 (0.70) ESR1ESR2PDCD1CD274APP
SCHEMBL10145543 0.87 ALDH1A1 (0.61) ESR1ESR2PDCD1CD274ALDH1A1
SCHEMBL3893552 0.87 ALDH1A1 (0.61) ESR1ESR2PDCD1CD274ALDH1A1
SCHEMBL6338007 0.83 SLC2A1 (0.59) ESR1ESR2PDCD1CD274APP
4-Dimethylaminophenol SCHEMBL23467138 0.82 APP (0.61) ESR1ESR2PDCD1CD274APP
4-Dimethylaminophenol SCHEMBL224308 0.82 APP (0.73) APPALDH1A1TSHRALOX15HSD17B10
4-Dimethylaminophenol SCHEMBL9792507 0.82 APP (0.73) APPALDH1A1TSHRALOX15HSD17B10
SCHEMBL26946 0.82 ESR1 (1.00) ESR1ESR2PDCD1CD274ALDH1A1
SCHEMBL10593295 0.82 ESR1 (1.00) ESR1ESR2PDCD1CD274ALDH1A1
Ammonia Solution, Strong SCHEMBL7989093 0.79 ESR1 (0.94) ESR1ESR2PDCD1CD274ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050080260-A1 Preparation of prodrugs for selective drug delivery LUMINIDE 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080260-A1 Preparation of prodrugs for selective drug delivery APEH, PAH, ALAD ESR1 362/4885ESR2 507/4885PDCD1 438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.